Sphera Funds Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-16,096
Closed -$136K 120
2023
Q4
$136K Sell
16,096
-168,920
-91% -$1.96M 0.02% 96
2023
Q3
$3.17M Buy
+185,016
New +$3.63M 0.58% 56
2022
Q2
Sell
-212,640
Closed -$3.61M 76
2022
Q1
$3.61M Buy
+212,640
New +$4.01M 0.51% 44

Other funds holding REPL

Sphera Funds Management's REPL Position: Q1 2024 in Review

Sphera Funds Management sold out of Replimune Group (REPL) in Q1 2024, closing a stake of 16,096 shares — an estimated $136K sold.

Sphera Funds Management first reported a position in REPL in Q1 2022 and held it in 3 quarters. The position peaked at $3.61M in Q1 2022. 150 funds tracked by Wall St. Rank hold REPL as of Q1 2024.

  • Sphera Funds Management reported no remaining Replimune Group position as of Q1 2024 after selling out during the quarter.
  • Sphera Funds Management sold 16,096 Replimune Group shares in Q1 2024, an estimated $136K.
  • Sphera Funds Management first reported a position in Replimune Group in Q1 2022 and held it in 3 quarters.
  • Sphera Funds Management's Replimune Group position peaked at $3.61M in Q1 2022.
  • 150 funds tracked by Wall St. Rank held Replimune Group as of Q1 2024.

Based on Sphera Funds Management's 13F filing for Q1 2024, filed 15 May 2024.